| Literature DB >> 33603637 |
Uche C Njoku1, Peter U Amadi2, Joy A Amadi3.
Abstract
OBJECTIVES: This study examined the influence of nutrition on the severity of menstrual pains and associated transient changes in blood pressure (BP) and vascular-health indicators. It has also investigated the influence of nutrition on angiotensin (ANG II) and vascular cell adhesion molecules (VCAM-1).Entities:
Keywords: Blood pressure; Dysmenorrhoea; Nutrition; Pain; Vascular
Year: 2020 PMID: 33603637 PMCID: PMC7858019 DOI: 10.1016/j.jtumed.2020.10.018
Source DB: PubMed Journal: J Taibah Univ Med Sci ISSN: 1658-3612
Figure 1Experimental groups of participants.
Demographic characteristics of participants.
| Parameters | Normal (n = 69) | Moderately painful (n = 69) | Severely painful (n = 69) |
|---|---|---|---|
| Age (yrs) | 18–24 (21.40 ± 2.2) | 18–24 (19.50 ± 2.62) | 18–25 (20.80 ± 2.0) |
| Menarche (yrs) | 12–14 (12.50 ± 0.50) | 12–15 (12.45 ± 0.60) | 11–15 (12.80 ± 0.70) |
| Age of first dysmenorrhoea (yrs) | – | 12–15 (13.26 ± 1.10) | 12–15 (13.84 ± 1.4) |
| Duration of Dysmenorrhoea (days) | – | 2–3 (2.45 ± 0.50) | 2–3 (2.45 ± 0.50) |
| BMI (kg/m2) | 18.74–34.20 (27.60 ± 4.82) | 19.60–31.58 (25.39 ± 6.38) | 19.10–30.90 (24.22 ± 5.73) |
BMI – body-mass index, note: (mean ± standard deviations) represents the numbers between brackets in the tables.
Contactin-1 (ng/ml) levels of control and dysmenorrhoeal participants fed 48 h before dysmenorrhoea for 3 months.
| Foods | No dysmenorrhoea n = 69 | Moderate Dysmenorrhoea n = 69 | Severe Dysmenorrhoea n = 69 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Baseline | 1st Month | 3rd Month | Baseline | 1st Month | 3rd Month | Baseline | 1st Month | 3rd Month | |
| Vegetables | 8.31 ± 0.71 (7.30–9.40) | 8.09 ± 0.64 (7.30–9.10) | 8.05 ± 0.69 (7.10–9.10) | 27.48 ± 3.87 (20.60–35.20) | 16.98 ± 4.78# (11.60–29.30) | 9.61 ± 2.37∗∗ (7.10–15.40) | 45.68 ± 4.74 (38.50–52.80) | 22.93 ± 8.54∗ (14.00–41.40) | 11.23 ± 4.56∗∗ (7.20–24.10) |
| C–N -D (%) | – | – | – | 69.6 | – | 56.5 | |||
| C-Mi-D (%) | – | – | 82.6 | 30.4 | 56.5 | 34.8 | |||
| C–Mo-D (%) | – | – | 17.4 | – | 30.5 | 8.7 | |||
| C–S-D (%) | – | – | – | – | 13.0 | – | |||
| Proteins | 8.10 ± 0.63 (7.10–9.10) | 8.13 ± 0.74 (7.20–9.20) | 8.06 ± 0.72 (7.10–9.20) | 25.15 ± 4.66 (18.10–32.70) | 27.62 ± 4.36 (20.40–37.20) | 37.32 ± 6.15 (26.30–51.20) | 46.35 ± 4.49 (39.80–53.40) | 48.73 ± 3.91 (40.60–55.20) | 52.43 ± 4.86 (44.90–61.90) |
| C–N -D (%) | – | – | – | – | – | – | |||
| C-Mi-D (%) | – | – | – | – | – | – | |||
| C–Mo-D (%) | – | – | 100 | 26.1 | – | – | |||
| C–S-D (%) | – | – | – | 73.9 | 100 | 100 | |||
| Carbohydrates | 8.35 ± 0.67 (7.50–9.60) | 8.23 ± 0.75 (7.30–9.20) | 11.48 ± 5.5∗# (7.40–21.70) | 26.61 ± 4.71 (17.40–34.20) | 46.42 ± 4.85## (38.60–54.50) | 48.17 ± 4.93## (41.20–60.50) | 45.76 ± 4.85 (38.20–54.10) | 53.86 ± 5.15 (48.60–65.30) | 58.69 ± 5.34 (49.20–67.40) |
| C–N -D (%) | – | – | – | – | – | – | |||
| C-Mi-D (%) | – | 20 | – | – | – | – | |||
| C–Mo-D (%) | – | 20 | – | – | – | – | |||
| C–S-D (%) | – | – | 100 | 100 | 100 | 100 | |||
Note: (mean ± standard deviations) represents the numbers between brackets in the tables. C–N-D – Change to no dysmenorrhoea, C-Mi-D – Change to mild dysmenorrhoea, C–Mo-D – Change to moderate dysmenorrhoea, C–S-D – Change to severe dysmenorrhoea, # - Significantly lower than the moderate dysmenorrhoea baseline but higher than the control baseline, ## - Comparable to the severe dysmenorrhoea baseline, ∗ - Significantly lower than the severe dysmenorrhoea baseline but higher than the control baseline, ∗∗- No significant difference from the control baseline, ∗# - Significantly higher than the control baseline.
Third month blood-pressure frequency table; dysmenorrhoeal participants ate 48hrs before dysmenorrhoea for 3 months.
| BP (mm/Hg) | Number of participants (%) | |||||
|---|---|---|---|---|---|---|
| Control | Moderate Dysmenorrhoea | Severe Dysmenorrhoea | ||||
| Baseline | 3rd Month | Baseline | 3rd Month | Baseline | 3rd Month | |
| 120/70 | 4 | 0 | – | 0 | 0 | 0 |
| 120/80 | 96 | 100 | 39 | 43 | 0 | 61 |
| 120/90 | 0 | 0 | 9 | 5 | 9 | 9 |
| 130/80 | 0 | 0 | 13 | 43 | 0 | 17 |
| 130/90 | 0 | 0 | 39 | 9 | 61 | 13 |
| 140/90 | 0 | 0 | 0 | 0 | 26 | 0 |
| 140/100 | 0 | 0 | 0 | 0 | 4 | 0 |
| 120/80 | 100 | 92 | 26 | 31 | 0 | 0 |
| 120/90 | 0 | 0 | 17 | 13 | 22 | 17 |
| 130/80 | 0 | 9 | 31 | 17 | 9 | 0 |
| 130/90 | 0 | 0 | 26 | 39 | 56 | 65 |
| 140/90 | 0 | 0 | 0 | 0 | 13 | 18 |
| 120/70 | 0 | 4 | 0 | 0 | 0 | 0 |
| 120/80 | 100 | 61 | 22 | 9 | 4 | 0 |
| 120/90 | 0 | 9 | 26 | 4 | 9 | 0 |
| 130/80 | 0 | 13 | 35 | 17 | 22 | 17 |
| 130/90 | 0 | 13 | 17 | 44 | 48 | 22 |
| 140/90 | 0 | 0 | 0 | 17 | 17 | 17 |
| 140/100 | 0 | 0 | 0 | 0 | 0 | 13 |
| 150/90 | 0 | 0 | 0 | 0 | 0 | 9 |
| 150/100 | 0 | 0 | 0 | 9 | 0 | 22 |
BP – Blood pressure.
Figure 2a) Correlation graph showing ANG-II levels at baseline and the 3rd month levels in intervention groups; b) Mean ANG-II levels of control and dysmenorrhoeal participants by 48-hr pre-menstrual choice of food; c) correlation graph showing VCAM-1 levels at baseline and at the 3rd month across the intervention groups; d) Mean VCAM-1 levels of control and dysmenorrhoeal participants by 48-hr pre-menstrual choice of food. Baseline – measurement for all intervention groups: a – no significant difference with the control baseline; b – significantly higher than the control baseline.